You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serous epithelial ovarian cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

Terminated
  • Ovarian Cancer
  • +21 more
  • Exercise Counseling
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 6, 2022

Ovarian Cancer, High Grade Ovarian Serous Trial in New York (PET/MRI, Contrast enhanced CT)

Active, not recruiting
  • Ovarian Cancer
  • High Grade Ovarian Serous
  • PET/MRI
  • Contrast enhanced CT
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Mar 2, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

Recruiting
  • Advanced Fallopian Tube Carcinoma
  • +21 more
  • Biopsy
  • +2 more
  • Bethesda, Maryland
  • +2 more
Jan 25, 2023

miRNAs in High Grade Serous Ovarian Cancer

Recruiting
  • High Grade Serous Ovarian Cancer
    • Bologna, Bo, Italy
      IRCCS- Azienda Ospedaliera-Universitaria di Bologna
    Dec 3, 2021

    Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

    Recruiting
    • Deleterious BRCA1 Gene Mutation
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 23, 2022

    Pembrolizumab and Anlotinib in Treatment of High-Grade Serous

    Completed
    • High-Grade Serous Ovarian Cancer
    • Pembrolizumab combined Anlotinib
    • Qingdao, Shandong, China
      Xiaochun Zhang
    Dec 26, 2021

    Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

    Not yet recruiting
    • Advanced Solid Tumor
    • +18 more
    • (no location specified)
    Aug 10, 2022

    Ovarian Cancer Stage IV, Peritoneal Cancer, Fallopian Tube Cancer Trial in Amsterdam (Carboplatin, Paclitaxel, Pembrolizumab)

    Recruiting
    • Ovarian Cancer Stage IV
    • +2 more
    • Amsterdam, Netherlands
      Antoni van Leeuwenhoek
    Mar 21, 2022

    Ovarian Cancer Trial in Manchester (Olaparib, Cediranib, Platinum-based Chemotherapy)

    Completed
    • Ovarian Cancer
    • Manchester, United Kingdom
      The Christie NHS Foundation Trust
    Feb 4, 2022

    Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

    Not yet recruiting
    • Ovarian Clear Cell Adenocarcinoma
    • +14 more
    • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
    • +4 more
    • Buffalo, New York
    • +1 more
    Dec 16, 2022

    Hyperthermic Intraperitoneal Chemo, Neoadjuvant Chemo Trial in Guangzhou (HIPEC, intravenous chemo)

    Recruiting
    • Hyperthermic Intraperitoneal Chemotherapy
    • Neoadjuvant Chemotherapy
    • HIPEC
    • intravenous chemotherapy
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen Memorial Hospital
    Feb 17, 2022

    Renal Cell Carcinoma (RCC), Urothelial Carcinoma, Primary Peritoneal Cancer Trial in Canada, United States (DSP-7888 Dosing

    Completed
    • Renal Cell Carcinoma (RCC)
    • +5 more
    • DSP-7888 Dosing Emulsion
    • +2 more
    • Tucson, Arizona
    • +18 more
    Dec 6, 2022

    Ovarian Cancer Trial in Oklahoma City (Unesbulin)

    Active, not recruiting
    • Ovarian Cancer
    • Oklahoma City, Oklahoma
      University of Oklahoma Health Sciences Center
    Feb 21, 2022

    Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)

    Suspended
    • Brenner Tumor
    • +27 more
    • metformin hydrochloride
    • +2 more
    • Birmingham, Alabama
    • +9 more
    May 16, 2022

    High-grade Serous Ovarian Cancer Trial in Belgium, Spain, United Kingdom (APR-246, Pegylated Liposomal Doxorubicin Hydrochloride

    Completed
    Has Results
    • High-grade Serous Ovarian Cancer
    • APR-246
    • Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
    • Gent, Belgium
    • +11 more
    Jul 19, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinosarcoma Trial in Germany, United Kingdom (Paclitaxel, TAK228)

    Active, not recruiting
    • Ovarian Cancer
    • +9 more
    • Berlin, Germany
    • +14 more
    Mar 10, 2022

    Ovarian Cancer Trial in Groningen (DCP-001)

    Recruiting
    • Ovarian Cancer
    • DCP-001
    • Groningen, Netherlands
      UMCG
    Nov 25, 2021

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

    Active, not recruiting
    Has Results
    • BRCA1 Gene Mutation
    • +5 more
    • Durvalumab
    • +3 more
    • Buffalo, New York
    • +1 more
    Jan 20, 2023

    Capturing BRCA1/2 Mutational Status in High Grade Serous Ovarian

    Active, not recruiting
    • Ovarian Cancer
    • BRCA genetic data
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Sep 29, 2021

    Developing a Test for the Detection of Ovarian Cancer

    Recruiting
    • Ovarian Neoplasms
    • +14 more
    • Uterine lavage, or a wash of the womb
    • +2 more
    • Little Rock, Arkansas
    • +5 more
    Apr 29, 2022

    Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal

    Recruiting
    • Platinum-Refractory Fallopian Tube Carcinoma
    • +11 more
    • Copanlisib Hydrochloride
    • +4 more
    • Aurora, Colorado
    • +2 more
    Dec 8, 2022

    Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

    Recruiting
    • Platinum-resistant Ovarian Cancer
    • +6 more
    • olvimulogene nanivacirepvec
    • +3 more
    • Orlando, Florida
      AdventHealth Cancer Institute
    Sep 1, 2022

    Variance of HRD From Paired Ovarian Cancer

    Not yet recruiting
    • Ovarian Cancer
    • +2 more
      • Nanjing, Jiangsu, China
        Xiaoxiang Chen
      Sep 25, 2021

      BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston (Chemotherapy, Olaparib, Therapeutic

      Recruiting
      • BRCA-Mutated Ovarian Carcinoma
      • +30 more
      • Houston, Texas
        M D Anderson Cancer Center
      May 27, 2022